Smith & Nephew (SNN) Asset Utilization Ratio (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Asset Utilization Ratio of 0.96 for Q4 2024, down 99.84% on a QoQ basis from 607.44 in Q4 2022.
Smith & Nephew (SNN) Asset Utilization Ratio (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Asset Utilization Ratio for 13 consecutive years, with 0.96 the latest figure, recorded in Q4 2024.
- Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.96 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.96 (changed N/A YoY) and the FY2025 annual result came in at 0.59, down 47.12% from the prior year.
- Asset Utilization Ratio slipped to 0.96 in Q4 2024 per SNN's latest filing, from 607.44 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for SNN reached as high as 659.24 in Q4 2021 and fell as low as 0.96 in Q4 2024.
- A 4-year average of 317.4 and a median of 304.69 in 2020 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2020 — Asset Utilization Ratio dropped 9.1% — and 2021, when it surged 33755.62%.
- Year by year, Asset Utilization Ratio stood at 1.95 in 2020, then jumped by 33755.62% to 659.24 in 2021, then fell by 7.86% to 607.44 in 2022, then plunged by 99.84% to 0.96 in 2024.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.96, 607.44, and 659.24 for Q4 2024, Q4 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.96 |
| Dec 31, 2022 | 607.44 |
| Dec 31, 2021 | 659.24 |
| Dec 31, 2020 | 1.95 |
| Dec 31, 2019 | 2.14 |
| Dec 31, 2018 | 2.42 |
| Dec 31, 2017 | 2.49 |
| Dec 31, 2016 | 1.10 |
| Dec 31, 2015 | 0.96 |
| Dec 31, 2014 | 0.76 |
| Sep 30, 2014 | 0.60 |
| Mar 31, 2014 | 0.78 |
| Dec 31, 2013 | 0.77 |
| Mar 31, 2013 | 0.79 |
| Dec 31, 2012 | 1.40 |
| Jun 30, 2012 | -886,115.39 |
| Mar 31, 2012 | 2.25 |
| Dec 31, 2009 | 0.78 |
| Sep 30, 2009 | 1.17 |
| Jun 30, 2009 | 210,813.26 |